OVID THERAPEUTICS INC's ticker is OVID and the CUSIP is 690469101. A total of 95 filers reported holding OVID THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.63 and the average weighting 0.1%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $114,275 | +21.4% | 29,759 | +3.7% | 0.00% | 0.0% |
| Q2 2023 | $94,139 | -15.2% | 28,701 | +3.5% | 0.00% | – |
| Q1 2021 | $111,000 | +73.4% | 27,729 | +0.3% | 0.00% | – |
| Q4 2020 | $64,000 | -56.5% | 27,655 | +8.0% | 0.00% | -100.0% |
| Q3 2020 | $147,000 | -23.8% | 25,600 | -2.2% | 0.00% | 0.0% |
| Q2 2020 | $193,000 | +1186.7% | 26,183 | +211.7% | 0.00% | – |
| Q1 2019 | $15,000 | -28.6% | 8,401 | -3.1% | 0.00% | – |
| Q4 2018 | $21,000 | -58.0% | 8,674 | -0.8% | 0.00% | – |
| Q3 2018 | $50,000 | -25.4% | 8,741 | +1.8% | 0.00% | – |
| Q2 2018 | $67,000 | +21.8% | 8,583 | +9.5% | 0.00% | – |
| Q1 2018 | $55,000 | +61.8% | 7,840 | +130.4% | 0.00% | – |
| Q4 2017 | $34,000 | +17.2% | 3,403 | +0.5% | 0.00% | – |
| Q3 2017 | $29,000 | -12.1% | 3,386 | +8.1% | 0.00% | – |
| Q2 2017 | $33,000 | – | 3,132 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TLS Advisors LLC | 1,380,346 | $3,516 | 18.08% |
| Madison Avenue Partners, LP | 3,104,603 | $8,009,876 | 1.72% |
| BVF INC/IL | 6,851,051 | $17,675,712 | 0.65% |
| CHI Advisors LLC | 864,822 | $2,231,241 | 0.59% |
| EcoR1 Capital, LLC | 6,117,400 | $15,782,892 | 0.51% |
| Rubric Capital Management LP | 7,001,124 | $18,062,900 | 0.47% |
| Artal Group S.A. | 2,500,000 | $6,450 | 0.38% |
| Tejara Capital Ltd | 118,791 | $306,481 | 0.16% |
| DCF Advisers, LLC | 68,264 | $176,120 | 0.11% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 827,580 | $2,135,156 | 0.06% |